{"id":"https://openalex.org/W2114469271","doi":null,"title":"Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.","display_name":"Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.","alternate_titles":[],"publication_year":1996,"publication_date":"1996-09-01","ids":{"openalex":"https://openalex.org/W2114469271","mag":"2114469271","pmid":"https://pubmed.ncbi.nlm.nih.gov/9816324"},"language":"en","primary_location":{"id":"pmid:9816324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2114469271"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111425336","display_name":"Lawrence W. Anderson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L W Anderson","raw_affiliation_strings":["Division of Clinical Pharmacology Research, U.S. Food and Drug Administration, Center for Drug Evaluation and Research, OTR, Laurel, Maryland 20708, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology Research, U.S. Food and Drug Administration, Center for Drug Evaluation and Research, OTR, Laurel, Maryland 20708, USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059383380","display_name":"T L Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T L Chen","raw_affiliation_strings":["Johns Hopkins University ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University (","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002034160","display_name":"O. Michael Colvin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O M Colvin","raw_affiliation_strings":["Johns Hopkins University ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University (","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108362825","display_name":"L B Grochow","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L B Grochow","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026863845","display_name":"Jerry M. Collins","orcid":"https://orcid.org/0009-0008-7186-4101","observed_orcids":["https://orcid.org/0009-0008-7186-4101"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J M Collins","raw_affiliation_strings":["United States Food and Drug Administration,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United States Food and Drug Administration,","institution_ids":["https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M J Kennedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M J Kennedy","raw_affiliation_strings":["Johns Hopkins University ("],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University (","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113512364","display_name":"John M. Strong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J M Strong","raw_affiliation_strings":["United States Food and Drug Administration,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United States Food and Drug Administration,","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4486,"has_fulltext":false,"cited_by_count":56,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.7732342,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"2","issue":"9","first_page":"1481","last_page":"1487"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2800000011920929,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.2800000011920929,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.20839999616146088,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.06909999996423721,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/4-hydroxycyclophosphamide","display_name":"4-hydroxycyclophosphamide","score":0.984000027179718},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9649999737739563},{"id":"https://openalex.org/keywords/thiotepa","display_name":"thiotepa","score":0.9380000233650208},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.4959999918937683},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.8220000267028809},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.703000009059906},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C2779968505","wikidata":"https://www.wikidata.org/wiki/Q416507","display_name":"ThioTEPA","level":4,"score":0.7767301201820374},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5599596500396729},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5429882407188416},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5258662700653076},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5066059827804565},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4560241401195526},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.44824087619781494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4240204393863678},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3438088893890381},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.32352662086486816},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1842987835407257},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010752","descriptor_name":"Phosphoramide Mustards","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013852","descriptor_name":"Thiotepa","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013852","descriptor_name":"Thiotepa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9816324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial"},{"id":"mag:2114469271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9816324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1309437251","display_name":"PHASE II TRIALS OF NEW ANTICANCER AGENTS","funder_award_id":"U01CA063437","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3787777954","display_name":"Bone  Marrow Transplantation in Human Disease","funder_award_id":"P01CA015396","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W121677148","https://openalex.org/W1563609352","https://openalex.org/W1585563795","https://openalex.org/W1806607738","https://openalex.org/W1943279816","https://openalex.org/W1970149430","https://openalex.org/W1977921316","https://openalex.org/W1985609633","https://openalex.org/W1987186247","https://openalex.org/W2007482879","https://openalex.org/W2007825449","https://openalex.org/W2048226867","https://openalex.org/W2058911889","https://openalex.org/W2084468930","https://openalex.org/W2087525057","https://openalex.org/W2097657756","https://openalex.org/W2105257387","https://openalex.org/W2112381649","https://openalex.org/W2122471887","https://openalex.org/W2141605462","https://openalex.org/W2152445237","https://openalex.org/W2167880814","https://openalex.org/W2169036834","https://openalex.org/W2261881314","https://openalex.org/W2404819954","https://openalex.org/W2411733423","https://openalex.org/W2416527373"],"related_works":["https://openalex.org/W2036215475","https://openalex.org/W2087525057","https://openalex.org/W2073605116","https://openalex.org/W2416527373","https://openalex.org/W2059370719","https://openalex.org/W2061340969","https://openalex.org/W2129811244","https://openalex.org/W2245286236","https://openalex.org/W2134671666","https://openalex.org/W1992248095"],"abstract_inverted_index":{"Using":[0],"a":[1,40,48,61],"recently":[2],"developed":[3],"gas":[4],"chromatography":[5],"and":[6,15,86,92,122,179],"mass":[7],"spectrometry":[8],"method":[9],"to":[10,74,98,176,194,242],"determine":[11],"whole-blood":[12,174],"cyclophosphamide":[13],"(CP)":[14],"4-hydroxycyclophosphamide/aldophosphamide":[16],"(4-HO-CP/AP)":[17],"concentrations,":[18],"we":[19],"investigated":[20,219],"their":[21],"pharmacokinetics":[22],"in":[23,54,67,184,224,234],"women":[24],"receiving":[25],"CP":[26,75,178,204,214,232],"therapy.":[27],"Patients":[28],"(n":[29],"=":[30],"18)":[31],"received":[32],"one":[33],"or":[34,59],"two":[35],"courses":[36,90],"of":[37,119,209,213,231,249],"CP:":[38],"(a)":[39],"90-min":[41],"i.v.":[42,50,63],"infusion":[43,51,64],"(4":[44],"g/m2)":[45,53,66],"followed":[46],"by":[47,216],"96-h":[49,62],"(6":[52,65],"combination":[55,68],"with":[56,69,188,203],"high-dose":[57,70],"thiotepa;":[58],"(b)":[60],"thiotepa.":[71],"Whole-blood":[72],"exposures":[73,175],"[area":[76],"under":[77],"the":[78,107,110,123,138,149,156,166,206,246],"whole":[79],"blood":[80],"concentration":[81],"versus":[82],"time":[83],"curve":[84],"(AUCCP)]":[85],"4-HO-CP/AP":[87,180],"(AUC4HOCP)":[88],"between":[89,109],"1":[91],"2":[93],"were":[94,181],"compared":[95],"after":[96],"normalization":[97],"dose":[99],"(g/m2).":[100],"A":[101],"nonproportional":[102],"increase":[103],"was":[104,152,200,218],"observed":[105],"for":[106,148,165,229],"AUCCP":[108],"first":[111,150],"course":[112,125,151,168,208],"[1112":[113],"micrometer.":[114,244],"h/g/m2":[115,129,143,161],"+/-":[116,130,144,162],"14%":[117],"coefficient":[118],"variation":[120],"(CV)]":[121],"second":[124,167,207],"(1579":[126],"micrometer":[127,141,159],".":[128,142,160],"28%":[131],"CV)":[132,146,164],"(P":[133,169],"<":[134,170],"0.001).":[135],"In":[136],"contrast,":[137],"AUC4HOCP":[139,157],"(27":[140],"25%":[145],"determined":[147,228],"29%":[153],"higher":[154],"than":[155],"(21":[158],"26%":[163],"0.01).":[171],"The":[172],"interpatient":[173],"both":[177],"remarkably":[182],"consistent":[183],"this":[185,250],"patient":[186],"population":[187],"percent":[189],"CVs":[190],"ranging":[191],"from":[192,240],"14":[193],"28%.":[195],"Because":[196],"thiotepa":[197,217],"(800":[198],"mg/m2)":[199],"administered":[201],"simultaneously":[202],"during":[205],"treatment,":[210],"possible":[211],"inhibition":[212,230],"metabolism":[215,233],"using":[220],"human":[221],"liver":[222,237],"microsomes":[223],"vitro.":[225],"IC50":[226],"values":[227],"three":[235],"individual":[236],"donors":[238],"ranged":[239],"1.0":[241],"40":[243],"However,":[245],"clinical":[247],"relevance":[248],"observation":[251],"has":[252],"not":[253],"been":[254],"established.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2114469271","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
